Incyte (INCY) – Hot Corp. News
-
Incyte (INCY) Acquires Rights to Tafasitamab from MorphoSys (MOR)
-
Incyte (INCY) Phase 3 Trial Evaluating Ruxolitinib Cream in Children with Atopic Dermatitis Met Its Primary Endpoint
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to INCY Stock Lookup